Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes

Chest

Volumn 152, Issue 1, 2017, Pages 92-102

  Ramjug, Sheila ^a   Hussain, Nehal ^a   Hurdman, Judith ^a   Billings, Catherine ^a   Charalampopoulos, Athanasios ^a   Elliot, Charlie A ^a   Kiely, David G ^a   Sabroe, Ian ^a,b   Rajaram, Smitha ^c   Swift, Andrew J ^b,c   Condliffe, Robin ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

connective tissue disease; idiopathic; pulmonary hypertension; systemic sclerosis

Indexed keywords

CARBON MONOXIDE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; LUNG CAPILLARY; LUNG COMPLIANCE; LUNG DIFFUSION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY SATURATION; PULMONARY HYPERTENSION; RESPIRATORY TRACT PARAMETERS; RISK FACTOR; SURVIVAL TIME; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; COMPLICATION; ENGLAND; FAMILIAL PRIMARY PULMONARY HYPERTENSION; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG FUNCTION TEST; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VASCULAR RESISTANCE;

ADULT; AGE FACTORS; AGED; DEMOGRAPHY; ENGLAND; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VASCULAR RESISTANCE;

EID: 85022044840     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.02.010     Document Type: Article

References (40)

1. Hurdman, J., Condliffe, R., Elliot, C.A., et al. ASPIRE registry: assessing the Spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 39:4 (2012), 945–955.
2. Kawut, S.M., Taichman, D.B., Archer-Chicko, C.L., Palevsky, H.I., Kimmel, S.E., Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123:2 (2003), 344–350.
3. Chung, L., Liu, J., Parsons, L., et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138:6 (2010), 1383–1394.
4. Clements, P.J., Tan, M., McLaughlin, V.V., et al. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis 71:2 (2012), 249–252.
5. Fisher, M.R., Mathai, S.C., Champion, H.C., et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54:9 (2006), 3043–3050.
6. Ramjug, S., Hussain, N., Hurdman, J., et al. Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension. Respirology 22:2 (2017), 372–377.
7. Overbeek, M.J., Vonk, M.C., Boonstra, A., et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J 34:2 (2009), 371–379.
8. Overbeek, M.J., Lankhaar, J.W., Westerhof, N., et al. Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Eur Respir J 31:6 (2008), 1160–1166.
9. Tedford, R.J., Mudd, J.O., Girgis, R.E., et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail 6:5 (2013), 953–963.
10. Mathai, S.C., Bueso, M., Hummers, L.K., et al. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J 35:1 (2010), 95–104.
11. Condliffe, R., Howard, L.S., Connective tissue disease-associated pulmonary arterial hypertension. F1000Prime Rep, 7, 2015, 6.
12. Hoeper, M.M., Bogaard, H.J., Condliffe, R., et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62:25 suppl (2013), D42–D50.
13. Goh, N.S., Desai, S.R., Veeraraghavan, S., et al. Interstitial pulmonary disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:11 (2008), 1248–1254.
14. Reuben, S.R., Compliance of the human pulmonary arterial system in disease. Circ Res 29:1 (1971), 40–50.
15. Lankhaar, J.W., Westerhof, N., Faes, T.J., et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 291:4 (2006), H1731–H1737.
16. Lankhaar, J.W., Westerhof, N., Faes, T.J., et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 29:13 (2008), 1688–1695.
17. Mahapatra, S., Nishimura, R.A., Sorajja, P., Cha, S., McGoon, M.D., Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 47:4 (2006), 799–803.
18. Chemla, D., Castelain, V., Zhu, K., et al. Estimating right ventricular stroke work and the pulsatile work fraction in pulmonary hypertension. Chest 143:5 (2013), 1343–1350.
19. Swift, A.J., Rajaram, S., Hurdman, J., et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging 6:10 (2013), 1036–1047.
20. Swift, A.J., Capener, D., Hammerton, C., et al. Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterized by magnetic resonance imaging: pair-matched case controlled study. PLoS One, 10(5), 2015, e0127415.
21. Hagger, D., Condliffe, R., Woodhouse, N., et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) 48:9 (2009), 1137–1142.
22. England N. Clinical Commissioning Policy: National policy for targeted therapies for the treatment of pulmonary hypertension in adult. https://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2014/06/a11-ps-b.pdf. 2014; Accessed June 10, 2016.
23. Hadinnapola, C., Li, Q., Su, L., Pepke-Zaba, J., Toshner, M., The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease. Physiol Rep, 3(4), 2015.
24. Tedford, R.J., Determinants of right ventricular afterload (2013 Grover Conference series). Pulm Circ 4:2 (2014), 211–219.
25. Chemla, D., Castelain, V., Humbert, M., et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126:4 (2004), 1313–1317.
26. Condliffe, R., Kiely, D.G., Peacock, A.J., et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179:2 (2009), 151–157.
27. Ling, Y., Johnson, M.K., Kiely, D.G., et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186:8 (2012), 790–796.
28. Chung, L., Farber, H.W., Benza, R., et al. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest 146:6 (2014), 1494–1504.
29. Campo, A., Mathai, S.C., Le Pavec, J., et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 182:2 (2010), 252–260.
30. Chemla, D., Lau, E.M., Papelier, Y., Attal, P., Herve, P., Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. Eur Respir J 46:4 (2015), 1178–1189.
31. Saouti, N., Westerhof, N., Helderman, F., et al. RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 297:6 (2009), H2154–H2160.
32. Tedford, R.J., Hassoun, P.M., Mathai, S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 125:2 (2012), 289–297.
33. MacKenzie Ross, R.V., Toshner, M.R., Soon, E., Naeije, R., Pepke-Zaba, J., Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 305:2 (2013), H259–H264.
34. Dorfmuller, P., Humbert, M., Perros, F., et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38:6 (2007), 893–902.
35. Overbeek, M.J., Mouchaers, K.T., Niessen, H.M., et al. Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension. Int J Rheumatol, 2010, 2010.
36. Hsu, S., Houston, B.A., Tampakakis, E., et al. Right ventricular functional reserve in pulmonary arterial hypertension. Circulation 133:24 (2016), 2413–2422.
37. Kelemen, B.W., Mathai, S.C., Tedford, R.J., et al. Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes. Pulm Circ 5:2 (2015), 327–334.
38. Langleben, D., Orfanos, S.E., Giovinazzo, M., et al. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Arthritis Rheum 58:4 (2008), 1156–1164.
39. Stewart, N.J., Leung, G., Norquay, G., et al. Experimental validation of the hyperpolarized 129 Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magn Reson Med 74 (2015), 196–207.
40. Humbert, M., Sitbon, O., Chaouat, A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173:9 (2006), 1023–1030.